Dark

Check out our Level2View

MACK
Merrimack Pharmaceuticals, Inc.
stock NASDAQ

Inactive

May 17, 2024

15.13USD0.000%(0.00)1,255,765

Pre-market

0.00USD-100.000%(-15.13)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 27, 2022

05:01AM EST 41 Biggest Movers From Yesterday Benzinga

Nov 5, 2021

09:33AM EDT Merrimack Pharmaceuticals Q3 EPS $(0.04) Up From $(0.08) YoY Benzinga

Nov 4, 2021

05:00PM EDT Merrimack Reports Third Quarter 2021 Financial Results Business Wire

Aug 5, 2021

06:11PM EDT Merrimack Pharmaceuticals Q2 EPS $(0.06) Up From $(0.09) YoY Benzinga

04:30PM EDT Merrimack Reports Second Quarter 2021 Financial Results Business Wire

Jun 7, 2021

02:10PM EDT Elevation Oncology Files for $100M IPO Benzinga

May 28, 2021

08:00AM EDT 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced that it has appointed Russell T. Ray, MBA and Teresa DeLuca MD, MBA to its Board of Directors (Board) effective June 15, 2021. GlobeNewswire Inc

Apr 18, 2021

08:52AM EDT Last Week's Notable Insider Buys Included Evergy, StoneMor, Tattooed Chef And More Benzinga

Mar 10, 2021

06:00PM EST Merrimack Reports Full Year 2020 Financial Results Business Wire

Feb 18, 2021

08:14AM EST The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout Benzinga

Feb 11, 2021

11:21AM EST Stocks That Hit 52-Week Highs On Thursday Benzinga

Dec 11, 2020

08:11AM EST The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street Benzinga

Dec 10, 2020

07:42AM EST The Daily Biotech Pulse: Key Vaccine Adcom Review For Pfizer-BioNTech, Puma, Immutep, G1 Rally On Breast Cancer Conference Presentations Benzinga

Dec 8, 2020

08:04AM EST The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings Benzinga

Dec 2, 2020

02:06PM EST Why Merrimack's Stock Is Trading Higher Today Benzinga

Nov 5, 2020

08:25AM EST Merrimack Q3 Net Loss $1.0 Mln Or $0.08 Per Basic Share RTTNews

08:24AM EST Merrimack Pharmaceuticals Q3 EPS $(0.08) Up From $(0.21) YoY Benzinga

08:20AM EST Merrimack Reports Third Quarter 2020 Financial Results Business Wire

Aug 7, 2020

08:24AM EDT Merrimack Q2 Net Loss $1.2 Mln Or $0.09/Shr Vs Loss Of $9.4 mln Or $0.71/Shr Last Year RTTNews

08:20AM EDT Merrimack Reports Second Quarter 2020 Financial Results Business Wire

Share